Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 9.13091367 |
2 | Golgi transport vesicle coating (GO:0048200) | 9.13091367 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.75155806 |
4 | protein retention in ER lumen (GO:0006621) | 6.10881828 |
5 | COPII vesicle coating (GO:0048208) | 5.92259508 |
6 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.07682149 |
7 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.03383297 |
8 | positive regulation of nuclease activity (GO:0032075) | 4.90757861 |
9 | regulation of nuclease activity (GO:0032069) | 4.48724551 |
10 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.47462648 |
11 | 4-hydroxyproline metabolic process (GO:0019471) | 4.40083541 |
12 | cellular response to unfolded protein (GO:0034620) | 4.33082894 |
13 | signal peptide processing (GO:0006465) | 4.27900641 |
14 | protein maturation by protein folding (GO:0022417) | 4.19841685 |
15 | cellular response to topologically incorrect protein (GO:0035967) | 4.15864901 |
16 | ER-nucleus signaling pathway (GO:0006984) | 4.14144560 |
17 | vesicle coating (GO:0006901) | 4.05080252 |
18 | protein localization to endosome (GO:0036010) | 3.97320714 |
19 | sequestering of metal ion (GO:0051238) | 3.94863599 |
20 | exocrine pancreas development (GO:0031017) | 3.91059818 |
21 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.87752528 |
22 | basement membrane organization (GO:0071711) | 3.85861330 |
23 | cell adhesion mediated by integrin (GO:0033627) | 3.80242881 |
24 | endocrine pancreas development (GO:0031018) | 3.62815630 |
25 | intestinal cholesterol absorption (GO:0030299) | 3.53168154 |
26 | response to endoplasmic reticulum stress (GO:0034976) | 3.52224994 |
27 | hemidesmosome assembly (GO:0031581) | 3.50888543 |
28 | peptide hormone processing (GO:0016486) | 3.41117257 |
29 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.35277959 |
30 | peptidyl-asparagine modification (GO:0018196) | 3.34850034 |
31 | response to unfolded protein (GO:0006986) | 3.34681689 |
32 | low-density lipoprotein particle clearance (GO:0034383) | 3.32819654 |
33 | cell-substrate junction assembly (GO:0007044) | 3.31352463 |
34 | intestinal absorption (GO:0050892) | 3.31276859 |
35 | endodermal cell differentiation (GO:0035987) | 3.30122728 |
36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.29619485 |
37 | protein carboxylation (GO:0018214) | 3.29619485 |
38 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.29443903 |
39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.26140743 |
40 | L-phenylalanine metabolic process (GO:0006558) | 3.26140743 |
41 | desmosome organization (GO:0002934) | 3.26124615 |
42 | response to topologically incorrect protein (GO:0035966) | 3.25834285 |
43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.25728287 |
44 | L-phenylalanine catabolic process (GO:0006559) | 3.25728287 |
45 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.25014205 |
46 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.24755420 |
47 | pinocytosis (GO:0006907) | 3.20366905 |
48 | barbed-end actin filament capping (GO:0051016) | 3.16477167 |
49 | tricarboxylic acid metabolic process (GO:0072350) | 3.06840865 |
50 | type B pancreatic cell development (GO:0003323) | 3.06801043 |
51 | protein N-linked glycosylation (GO:0006487) | 3.05284718 |
52 | regulation of cholesterol homeostasis (GO:2000188) | 3.05228529 |
53 | regulation of early endosome to late endosome transport (GO:2000641) | 3.04557212 |
54 | regulation of extracellular matrix disassembly (GO:0010715) | 3.03796238 |
55 | cellular response to vitamin D (GO:0071305) | 3.03670289 |
56 | alpha-linolenic acid metabolic process (GO:0036109) | 3.02694847 |
57 | proline metabolic process (GO:0006560) | 3.01147843 |
58 | valine metabolic process (GO:0006573) | 3.00579042 |
59 | negative regulation of fibrinolysis (GO:0051918) | 3.00547833 |
60 | negative regulation of fatty acid transport (GO:2000192) | 2.99958265 |
61 | adherens junction assembly (GO:0034333) | 2.99164773 |
62 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.97495029 |
63 | focal adhesion assembly (GO:0048041) | 2.95402430 |
64 | cell-substrate adherens junction assembly (GO:0007045) | 2.95402430 |
65 | apoptotic cell clearance (GO:0043277) | 2.94871393 |
66 | regulation of plasminogen activation (GO:0010755) | 2.93879760 |
67 | epithelial cell-cell adhesion (GO:0090136) | 2.92985312 |
68 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.92304122 |
69 | sulfur amino acid catabolic process (GO:0000098) | 2.91904284 |
70 | hyaluronan catabolic process (GO:0030214) | 2.90368518 |
71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.89276033 |
72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.89276033 |
73 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.88363837 |
74 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.87944945 |
75 | proline biosynthetic process (GO:0006561) | 2.80205364 |
76 | protein autoprocessing (GO:0016540) | 2.78159728 |
77 | peptide catabolic process (GO:0043171) | 2.77117270 |
78 | peptidyl-proline hydroxylation (GO:0019511) | 2.75193076 |
79 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.75166248 |
80 | glandular epithelial cell development (GO:0002068) | 2.74881282 |
81 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.74100626 |
82 | glucose 6-phosphate metabolic process (GO:0051156) | 2.72369639 |
83 | membrane protein ectodomain proteolysis (GO:0006509) | 2.72143467 |
84 | lysine metabolic process (GO:0006553) | 2.72080749 |
85 | lysine catabolic process (GO:0006554) | 2.72080749 |
86 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.72040639 |
87 | skin morphogenesis (GO:0043589) | 2.70572361 |
88 | embryonic process involved in female pregnancy (GO:0060136) | 2.69984737 |
89 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.68976871 |
90 | keratan sulfate catabolic process (GO:0042340) | 2.67869227 |
91 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.66693742 |
92 | adhesion of symbiont to host (GO:0044406) | 2.66106577 |
93 | glucose catabolic process (GO:0006007) | 2.65428030 |
94 | lipoprotein metabolic process (GO:0042157) | 2.65117199 |
95 | cysteine metabolic process (GO:0006534) | 2.64782562 |
96 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.63429902 |
97 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.63358935 |
98 | stress fiber assembly (GO:0043149) | 2.63030913 |
99 | NADH metabolic process (GO:0006734) | 2.62484413 |
100 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62371387 |
101 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.60831875 |
102 | regulation of metalloenzyme activity (GO:0048552) | 2.60226287 |
103 | positive regulation of extracellular matrix organization (GO:1903055) | 2.59550532 |
104 | plasma lipoprotein particle clearance (GO:0034381) | 2.59422871 |
105 | cellular response to vitamin (GO:0071295) | 2.59388100 |
106 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.57310298 |
107 | positive regulation of glycolytic process (GO:0045821) | 2.57182345 |
108 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.56284418 |
109 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.55287548 |
110 | GDP-mannose metabolic process (GO:0019673) | 2.54970022 |
111 | maternal placenta development (GO:0001893) | 2.54809601 |
112 | cellular zinc ion homeostasis (GO:0006882) | 2.54737658 |
113 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.53956400 |
114 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.51000296 |
115 | pentose-phosphate shunt (GO:0006098) | 2.50845134 |
116 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.49220810 |
117 | complement activation, alternative pathway (GO:0006957) | 2.48417231 |
118 | collagen fibril organization (GO:0030199) | 2.47523281 |
119 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.47094253 |
120 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.46440074 |
121 | protein hydroxylation (GO:0018126) | 2.46435258 |
122 | regulation of fibrinolysis (GO:0051917) | 2.45580468 |
123 | macroautophagy (GO:0016236) | 2.45543130 |
124 | cellular response to nutrient (GO:0031670) | 2.45335872 |
125 | high-density lipoprotein particle remodeling (GO:0034375) | 2.44680762 |
126 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.44662966 |
127 | negative regulation of cell size (GO:0045792) | 2.44208926 |
128 | glandular epithelial cell differentiation (GO:0002067) | 2.43784307 |
129 | nitrogen cycle metabolic process (GO:0071941) | 2.42214899 |
130 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.41889292 |
131 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.41860448 |
132 | hormone catabolic process (GO:0042447) | 2.41210475 |
133 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.40959356 |
134 | reverse cholesterol transport (GO:0043691) | 2.40791561 |
135 | aromatic amino acid family catabolic process (GO:0009074) | 2.40772822 |
136 | embryo implantation (GO:0007566) | 2.40503707 |
137 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.40114130 |
138 | acylglycerol homeostasis (GO:0055090) | 2.39185138 |
139 | triglyceride homeostasis (GO:0070328) | 2.39185138 |
140 | protein-lipid complex assembly (GO:0065005) | 2.38941005 |
141 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.38682153 |
142 | wound healing, spreading of epidermal cells (GO:0035313) | 2.38380602 |
143 | urea cycle (GO:0000050) | 2.38377020 |
144 | urea metabolic process (GO:0019627) | 2.38377020 |
145 | collagen metabolic process (GO:0032963) | 2.36251873 |
146 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.36003791 |
147 | glyoxylate metabolic process (GO:0046487) | 2.35383987 |
148 | activation of Rac GTPase activity (GO:0032863) | 2.35002687 |
149 | endothelial cell morphogenesis (GO:0001886) | 2.32903918 |
150 | regulation of protein activation cascade (GO:2000257) | 2.32868485 |
151 | regulation of extracellular matrix organization (GO:1903053) | 2.32867918 |
152 | extracellular matrix disassembly (GO:0022617) | 2.32822921 |
153 | plasma lipoprotein particle assembly (GO:0034377) | 2.32516935 |
154 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.31932466 |
155 | protein heterotrimerization (GO:0070208) | 2.31530272 |
156 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.31133325 |
157 | NADPH regeneration (GO:0006740) | 2.28392193 |
158 | * Golgi organization (GO:0007030) | 2.28253620 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.17684673 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.83935489 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.60683933 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.15107077 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.12177861 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.01546746 |
7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.96260525 |
8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.85681773 |
9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.40968499 |
10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.40944458 |
11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.37889278 |
12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.30424789 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26640099 |
14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.24821563 |
15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.18637377 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99128741 |
17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.96092872 |
18 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.92932292 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.89922777 |
20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.87749169 |
21 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.83919386 |
22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.83202832 |
23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82684458 |
24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77310507 |
25 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.66636987 |
26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.66287271 |
27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63493780 |
28 | MYC_22102868_ChIP-Seq_BL_Human | 1.63245741 |
29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.61043994 |
30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58636335 |
31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57614854 |
32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56270871 |
33 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.55618289 |
34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55157465 |
35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.53965793 |
36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.52269084 |
37 | ATF3_27146783_Chip-Seq_COLON_Human | 1.51025261 |
38 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.48869149 |
39 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47174136 |
40 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44953664 |
41 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.41699495 |
42 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.38790691 |
43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38785774 |
44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37769636 |
45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37394918 |
46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35763926 |
47 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.35576634 |
48 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.35310524 |
49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35172810 |
50 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.33108490 |
51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31204741 |
52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30266735 |
53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.30191622 |
54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30161782 |
55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.29786681 |
56 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28854931 |
57 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28368778 |
58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28192448 |
59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26574707 |
60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25973722 |
61 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.25310942 |
62 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.24513264 |
63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22884048 |
64 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.21922261 |
65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19962133 |
66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19470488 |
67 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19470488 |
68 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19171371 |
69 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.18109809 |
70 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.17984248 |
71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17753019 |
72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17339764 |
73 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16661297 |
74 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16559931 |
75 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16482461 |
76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15382875 |
77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15370172 |
78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13712886 |
79 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12986609 |
80 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.12589698 |
81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10097992 |
82 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07564511 |
83 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07447583 |
84 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.07430754 |
85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06550433 |
86 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05915844 |
87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04740806 |
88 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.03929128 |
89 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03737199 |
90 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.03589887 |
91 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.03576514 |
92 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02089217 |
93 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01926387 |
94 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01245616 |
95 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00490092 |
96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00280932 |
97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99819780 |
98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98869338 |
99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97697551 |
100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97079781 |
101 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96122066 |
102 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.95552107 |
103 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.94991658 |
104 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94921551 |
105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94512863 |
106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94292728 |
107 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.94110804 |
108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93916033 |
109 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.93505626 |
110 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93119604 |
111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92946696 |
112 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92807477 |
113 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92321835 |
114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92262071 |
115 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.92214977 |
116 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91965833 |
117 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.91517844 |
118 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91417783 |
119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91005696 |
120 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90869536 |
121 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90720158 |
122 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90389127 |
123 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90214648 |
124 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90118798 |
125 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89444005 |
126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88950858 |
127 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88463768 |
128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88241691 |
129 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.88138026 |
130 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.87996465 |
131 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87831524 |
132 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87831524 |
133 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.87589052 |
134 | MAF_26560356_Chip-Seq_TH1_Human | 0.86592202 |
135 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86484546 |
136 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.86094338 |
137 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.86089383 |
138 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85399864 |
139 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85030084 |
140 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.84080588 |
141 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.84046955 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 3.42634845 |
2 | MP0008438_abnormal_cutaneous_collagen | 3.26729393 |
3 | MP0002877_abnormal_melanocyte_morpholog | 3.10042550 |
4 | MP0005360_urolithiasis | 3.01709321 |
5 | MP0003705_abnormal_hypodermis_morpholog | 2.91056540 |
6 | MP0005365_abnormal_bile_salt | 2.74778373 |
7 | MP0005451_abnormal_body_composition | 2.53212066 |
8 | MP0003283_abnormal_digestive_organ | 2.43679723 |
9 | MP0009840_abnormal_foam_cell | 2.34882404 |
10 | MP0003195_calcinosis | 2.29890560 |
11 | MP0006054_spinal_hemorrhage | 2.23418747 |
12 | MP0005220_abnormal_exocrine_pancreas | 2.22521611 |
13 | MP0003252_abnormal_bile_duct | 2.21704313 |
14 | MP0003300_gastrointestinal_ulcer | 2.20356510 |
15 | MP0005085_abnormal_gallbladder_physiolo | 2.04488944 |
16 | MP0004858_abnormal_nervous_system | 1.92544151 |
17 | MP0001666_abnormal_nutrient_absorption | 1.91851869 |
18 | MP0005275_abnormal_skin_tensile | 1.88580737 |
19 | MP0005623_abnormal_meninges_morphology | 1.86842066 |
20 | MP0001944_abnormal_pancreas_morphology | 1.86824362 |
21 | MP0005083_abnormal_biliary_tract | 1.84240568 |
22 | MP0000013_abnormal_adipose_tissue | 1.79739754 |
23 | MP0002693_abnormal_pancreas_physiology | 1.77550471 |
24 | MP0003806_abnormal_nucleotide_metabolis | 1.73364538 |
25 | MP0005058_abnormal_lysosome_morphology | 1.70363984 |
26 | MP0003566_abnormal_cell_adhesion | 1.67430615 |
27 | MP0004233_abnormal_muscle_weight | 1.63839122 |
28 | MP0003941_abnormal_skin_development | 1.62269502 |
29 | MP0004264_abnormal_extraembryonic_tissu | 1.61981796 |
30 | MP0010352_gastrointestinal_tract_polyps | 1.55487557 |
31 | MP0003183_abnormal_peptide_metabolism | 1.54279931 |
32 | MP0009643_abnormal_urine_homeostasis | 1.51254786 |
33 | MP0010329_abnormal_lipoprotein_level | 1.49806891 |
34 | MP0008260_abnormal_autophagy | 1.46840011 |
35 | MP0005409_darkened_coat_color | 1.41161114 |
36 | MP0002796_impaired_skin_barrier | 1.39770720 |
37 | MP0003453_abnormal_keratinocyte_physiol | 1.38914215 |
38 | MP0009384_cardiac_valve_regurgitation | 1.37265516 |
39 | MP0002896_abnormal_bone_mineralization | 1.36437198 |
40 | MP0002909_abnormal_adrenal_gland | 1.36093299 |
41 | MP0000609_abnormal_liver_physiology | 1.36023653 |
42 | MP0009780_abnormal_chondrocyte_physiolo | 1.34649104 |
43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34372878 |
44 | MP0005503_abnormal_tendon_morphology | 1.33886918 |
45 | MP0005257_abnormal_intraocular_pressure | 1.32820445 |
46 | MP0003950_abnormal_plasma_membrane | 1.32115279 |
47 | MP0005023_abnormal_wound_healing | 1.32031760 |
48 | MP0002138_abnormal_hepatobiliary_system | 1.27421524 |
49 | MP0000678_abnormal_parathyroid_gland | 1.24566307 |
50 | MP0005501_abnormal_skin_physiology | 1.21399908 |
51 | MP0002078_abnormal_glucose_homeostasis | 1.20436900 |
52 | MP0005076_abnormal_cell_differentiation | 1.18785508 |
53 | MP0003436_decreased_susceptibility_to | 1.17891130 |
54 | MP0003191_abnormal_cellular_cholesterol | 1.17350425 |
55 | MP0000767_abnormal_smooth_muscle | 1.16369543 |
56 | MP0003279_aneurysm | 1.15831053 |
57 | MP0001915_intracranial_hemorrhage | 1.15830023 |
58 | MP0004272_abnormal_basement_membrane | 1.15210406 |
59 | MP0004043_abnormal_pH_regulation | 1.13401711 |
60 | MP0004782_abnormal_surfactant_physiolog | 1.13318648 |
61 | MP0010234_abnormal_vibrissa_follicle | 1.12286913 |
62 | MP0000003_abnormal_adipose_tissue | 1.11993168 |
63 | MP0000537_abnormal_urethra_morphology | 1.10106159 |
64 | MP0003329_amyloid_beta_deposits | 1.09797710 |
65 | MP0002089_abnormal_postnatal_growth/wei | 1.09658741 |
66 | MP0001533_abnormal_skeleton_physiology | 1.08822504 |
67 | MP0010030_abnormal_orbit_morphology | 1.06266223 |
68 | MP0002060_abnormal_skin_morphology | 1.05844022 |
69 | MP0005332_abnormal_amino_acid | 1.05753219 |
70 | MP0001661_extended_life_span | 1.04568038 |
71 | MP0002118_abnormal_lipid_homeostasis | 1.04545177 |
72 | MP0005319_abnormal_enzyme/_coenzyme | 1.04152056 |
73 | MP0002933_joint_inflammation | 1.03550789 |
74 | MP0002928_abnormal_bile_duct | 1.02116034 |
75 | MP0001216_abnormal_epidermal_layer | 1.00654325 |
76 | MP0000598_abnormal_liver_morphology | 0.98176717 |
77 | MP0001243_abnormal_dermal_layer | 0.98015968 |
78 | MP0003172_abnormal_lysosome_physiology | 0.97763411 |
79 | MP0001730_embryonic_growth_arrest | 0.96058309 |
80 | MP0003868_abnormal_feces_composition | 0.95463099 |
81 | MP0000462_abnormal_digestive_system | 0.94053555 |
82 | MP0001756_abnormal_urination | 0.93980601 |
83 | MP0001348_abnormal_lacrimal_gland | 0.93668364 |
84 | MP0003795_abnormal_bone_structure | 0.92970382 |
85 | MP0000733_abnormal_muscle_development | 0.92218987 |
86 | MP0002837_dystrophic_cardiac_calcinosis | 0.89608064 |
87 | MP0004947_skin_inflammation | 0.89376712 |
88 | MP0001542_abnormal_bone_strength | 0.88722130 |
89 | MP0005636_abnormal_mineral_homeostasis | 0.86154059 |
90 | MP0002295_abnormal_pulmonary_circulatio | 0.85496113 |
91 | MP0004185_abnormal_adipocyte_glucose | 0.85432263 |
92 | MP0005621_abnormal_cell_physiology | 0.85198709 |
93 | MP0005408_hypopigmentation | 0.85011676 |
94 | MP0005165_increased_susceptibility_to | 0.84782573 |
95 | MP0001958_emphysema | 0.84321824 |
96 | MP0000604_amyloidosis | 0.82572355 |
97 | MP0010386_abnormal_urinary_bladder | 0.82315128 |
98 | MP0010368_abnormal_lymphatic_system | 0.82276522 |
99 | MP0003303_peritoneal_inflammation | 0.81544002 |
100 | MP0000762_abnormal_tongue_morphology | 0.81116365 |
101 | MP0000467_abnormal_esophagus_morphology | 0.81020932 |
102 | MP0005390_skeleton_phenotype | 0.80760408 |
103 | MP0003448_altered_tumor_morphology | 0.80568176 |
104 | MP0000858_altered_metastatic_potential | 0.80457909 |
105 | MP0005375_adipose_tissue_phenotype | 0.79044368 |
106 | MP0003959_abnormal_lean_body | 0.78523743 |
107 | MP0000751_myopathy | 0.78470974 |
108 | MP0002086_abnormal_extraembryonic_tissu | 0.78062439 |
109 | MP0005084_abnormal_gallbladder_morpholo | 0.77882323 |
110 | MP0009053_abnormal_anal_canal | 0.77433926 |
111 | MP0000163_abnormal_cartilage_morphology | 0.76856771 |
112 | MP0005508_abnormal_skeleton_morphology | 0.75923365 |
113 | MP0003186_abnormal_redox_activity | 0.75194921 |
114 | MP0001765_abnormal_ion_homeostasis | 0.74938869 |
115 | MP0000613_abnormal_salivary_gland | 0.72066477 |
116 | MP0008469_abnormal_protein_level | 0.71929123 |
117 | MP0004019_abnormal_vitamin_homeostasis | 0.71497762 |
118 | MP0002234_abnormal_pharynx_morphology | 0.71442411 |
119 | MP0001881_abnormal_mammary_gland | 0.71305679 |
120 | MP0000490_abnormal_crypts_of | 0.70616697 |
121 | MP0009931_abnormal_skin_appearance | 0.69724556 |
122 | MP0002254_reproductive_system_inflammat | 0.69118400 |
123 | MP0001845_abnormal_inflammatory_respons | 0.68308351 |
124 | MP0005197_abnormal_uvea_morphology | 0.68259602 |
125 | MP0000627_abnormal_mammary_gland | 0.67981693 |
126 | MP0000534_abnormal_ureter_morphology | 0.67699066 |
127 | MP0003385_abnormal_body_wall | 0.67377570 |
128 | MP0009642_abnormal_blood_homeostasis | 0.67187281 |
129 | MP0004957_abnormal_blastocyst_morpholog | 0.66302656 |
130 | MP0005379_endocrine/exocrine_gland_phen | 0.65856249 |
131 | MP0000477_abnormal_intestine_morphology | 0.65158468 |
132 | MP0002080_prenatal_lethality | 0.64781318 |
133 | MP0005670_abnormal_white_adipose | 0.64330368 |
134 | MP0003091_abnormal_cell_migration | 0.64182066 |
135 | MP0001614_abnormal_blood_vessel | 0.64005246 |
136 | MP0001849_ear_inflammation | 0.63872479 |
137 | MP0002168_other_aberrant_phenotype | 0.63758900 |
138 | MP0002970_abnormal_white_adipose | 0.63075959 |
139 | MP0009672_abnormal_birth_weight | 0.63035137 |
140 | MP0002115_abnormal_skeleton_extremities | 0.62006108 |
141 | MP0005666_abnormal_adipose_tissue | 0.60670260 |
142 | MP0010771_integument_phenotype | 0.60179903 |
143 | MP0009333_abnormal_splenocyte_physiolog | 0.59517344 |
144 | MP0002998_abnormal_bone_remodeling | 0.59158074 |
145 | MP0008961_abnormal_basal_metabolism | 0.58431193 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic coma (HP:0001325) | 5.04115927 |
2 | Hypoglycemic seizures (HP:0002173) | 4.31701068 |
3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.30418899 |
4 | Protrusio acetabuli (HP:0003179) | 3.81239551 |
5 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70095532 |
6 | Symptomatic seizures (HP:0011145) | 3.57207269 |
7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.46162618 |
8 | Hyperglycemia (HP:0003074) | 3.33994956 |
9 | Premature rupture of membranes (HP:0001788) | 3.30300919 |
10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.24718027 |
11 | Deep venous thrombosis (HP:0002625) | 3.21724493 |
12 | Ketoacidosis (HP:0001993) | 3.20313504 |
13 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.19504496 |
14 | Mucopolysacchariduria (HP:0008155) | 3.19504496 |
15 | Late onset (HP:0003584) | 3.16900332 |
16 | Xanthomatosis (HP:0000991) | 3.04318930 |
17 | Cervical subluxation (HP:0003308) | 2.98464612 |
18 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.93725969 |
19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.93725969 |
20 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.93725969 |
21 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.92092417 |
22 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.92092417 |
23 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.89446009 |
24 | Dysostosis multiplex (HP:0000943) | 2.86212971 |
25 | Fragile skin (HP:0001030) | 2.84769445 |
26 | Intrahepatic cholestasis (HP:0001406) | 2.84575367 |
27 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.76655628 |
28 | Wormian bones (HP:0002645) | 2.76624785 |
29 | Spinal rigidity (HP:0003306) | 2.75404325 |
30 | Thoracolumbar scoliosis (HP:0002944) | 2.74211850 |
31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.73009419 |
32 | Short nail (HP:0001799) | 2.67885935 |
33 | Ketosis (HP:0001946) | 2.66936224 |
34 | Achilles tendon contracture (HP:0001771) | 2.65598591 |
35 | Osteolytic defects of the hand bones (HP:0009699) | 2.65135877 |
36 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.65135877 |
37 | Vascular tortuosity (HP:0004948) | 2.61906275 |
38 | Generalized aminoaciduria (HP:0002909) | 2.61801519 |
39 | Peritonitis (HP:0002586) | 2.61402452 |
40 | Abnormality of the Achilles tendon (HP:0005109) | 2.60535038 |
41 | Cerebral aneurysm (HP:0004944) | 2.57351033 |
42 | Insulin resistance (HP:0000855) | 2.57107669 |
43 | Bladder diverticulum (HP:0000015) | 2.56492102 |
44 | Arterial tortuosity (HP:0005116) | 2.55995385 |
45 | Abnormality of dentin (HP:0010299) | 2.53129739 |
46 | Ulnar bowing (HP:0003031) | 2.47695262 |
47 | Beaking of vertebral bodies (HP:0004568) | 2.42512618 |
48 | Abnormality of carpal bone ossification (HP:0006257) | 2.39657979 |
49 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.39460419 |
50 | Hyperacusis (HP:0010780) | 2.38453080 |
51 | Protuberant abdomen (HP:0001538) | 2.38270501 |
52 | Hypobetalipoproteinemia (HP:0003563) | 2.37154238 |
53 | Shallow orbits (HP:0000586) | 2.36947670 |
54 | Vacuolated lymphocytes (HP:0001922) | 2.36857955 |
55 | Skin nodule (HP:0200036) | 2.33247458 |
56 | Vertebral compression fractures (HP:0002953) | 2.28108507 |
57 | Aortic aneurysm (HP:0004942) | 2.25813966 |
58 | Abdominal distention (HP:0003270) | 2.25300180 |
59 | Thin bony cortex (HP:0002753) | 2.24455675 |
60 | Elbow flexion contracture (HP:0002987) | 2.24041546 |
61 | Aortic dissection (HP:0002647) | 2.20936928 |
62 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20644175 |
63 | Asymmetry of the thorax (HP:0001555) | 2.20575280 |
64 | Increased connective tissue (HP:0009025) | 2.20198155 |
65 | Abnormal ossification of hand bones (HP:0005921) | 2.19733934 |
66 | Aneurysm (HP:0002617) | 2.19677735 |
67 | Distal upper limb amyotrophy (HP:0007149) | 2.18101130 |
68 | Upper limb amyotrophy (HP:0009129) | 2.18101130 |
69 | Abnormal delivery (HP:0001787) | 2.16989684 |
70 | Distal lower limb amyotrophy (HP:0008944) | 2.16029049 |
71 | Cardiovascular calcification (HP:0011915) | 2.15990521 |
72 | Natal tooth (HP:0000695) | 2.15947976 |
73 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.15908282 |
74 | Metaphyseal cupping (HP:0003021) | 2.14795763 |
75 | Abnormality of purine metabolism (HP:0004352) | 2.14405014 |
76 | Disproportionate tall stature (HP:0001519) | 2.12376628 |
77 | Abnormal cartilage morphology (HP:0002763) | 2.09603157 |
78 | Genu recurvatum (HP:0002816) | 2.09038896 |
79 | Broad face (HP:0000283) | 2.08524696 |
80 | Fat malabsorption (HP:0002630) | 2.07951554 |
81 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.07511009 |
82 | Abnormality of oral frenula (HP:0000190) | 2.07208906 |
83 | Long toe (HP:0010511) | 2.07191940 |
84 | Hydroxyprolinuria (HP:0003080) | 2.06616955 |
85 | Abnormality of proline metabolism (HP:0010907) | 2.06616955 |
86 | Complement deficiency (HP:0004431) | 2.06504580 |
87 | Abnormal pancreas size (HP:0012094) | 2.05511985 |
88 | Follicular hyperkeratosis (HP:0007502) | 2.03094504 |
89 | Hand muscle atrophy (HP:0009130) | 2.02726180 |
90 | Nonimmune hydrops fetalis (HP:0001790) | 2.01911075 |
91 | Platyspondyly (HP:0000926) | 2.00528374 |
92 | Hemorrhage of the eye (HP:0011885) | 2.00470893 |
93 | Hypolipoproteinemia (HP:0010981) | 1.97233338 |
94 | Mitral regurgitation (HP:0001653) | 1.96798086 |
95 | Abnormal foot bone ossification (HP:0010675) | 1.95351693 |
96 | Conjugated hyperbilirubinemia (HP:0002908) | 1.95284685 |
97 | Hyperextensible skin (HP:0000974) | 1.94308010 |
98 | Elevated alkaline phosphatase (HP:0003155) | 1.93898378 |
99 | Myocardial infarction (HP:0001658) | 1.93701137 |
100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93513113 |
101 | Severe short stature (HP:0003510) | 1.92957816 |
102 | Abnormal tarsal ossification (HP:0008369) | 1.92197948 |
103 | Blue sclerae (HP:0000592) | 1.91216670 |
104 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91089349 |
105 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90102403 |
106 | Trismus (HP:0000211) | 1.89999922 |
107 | Ankyloglossia (HP:0010296) | 1.89850658 |
108 | Advanced eruption of teeth (HP:0006288) | 1.89037974 |
109 | Gout (HP:0001997) | 1.89016842 |
110 | Ankle contracture (HP:0006466) | 1.88867765 |
111 | Abnormality of complement system (HP:0005339) | 1.88673595 |
112 | Prolonged partial thromboplastin time (HP:0003645) | 1.88232265 |
113 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.88133472 |
114 | Generalized amyotrophy (HP:0003700) | 1.87041047 |
115 | Joint laxity (HP:0001388) | 1.86867422 |
116 | Flat acetabular roof (HP:0003180) | 1.85811780 |
117 | Vascular calcification (HP:0004934) | 1.85688565 |
118 | Coxa vara (HP:0002812) | 1.85407116 |
119 | Dilatation of the ascending aorta (HP:0005111) | 1.83811175 |
120 | Back pain (HP:0003418) | 1.81719225 |
121 | Ovoid vertebral bodies (HP:0003300) | 1.81575632 |
122 | Joint stiffness (HP:0001387) | 1.81393150 |
123 | Abnormality of the acetabulum (HP:0003170) | 1.81152552 |
124 | Distal lower limb muscle weakness (HP:0009053) | 1.81072207 |
125 | Large for gestational age (HP:0001520) | 1.80671454 |
126 | Atrophic scars (HP:0001075) | 1.80634398 |
127 | Soft skin (HP:0000977) | 1.79494191 |
128 | Hyperparathyroidism (HP:0000843) | 1.78392441 |
129 | Biconcave vertebral bodies (HP:0004586) | 1.77230765 |
130 | Neonatal short-limb short stature (HP:0008921) | 1.76884114 |
131 | Hypoalphalipoproteinemia (HP:0003233) | 1.76630661 |
132 | Cupped ribs (HP:0000887) | 1.76040209 |
133 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.75080647 |
134 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.73800227 |
135 | Thin skin (HP:0000963) | 1.72749992 |
136 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.72302510 |
137 | Ectopia lentis (HP:0001083) | 1.72245387 |
138 | Mitral stenosis (HP:0001718) | 1.71939666 |
139 | Osteoarthritis (HP:0002758) | 1.71841640 |
140 | Spondylolisthesis (HP:0003302) | 1.71694970 |
141 | Renal duplication (HP:0000075) | 1.69411718 |
142 | Insomnia (HP:0100785) | 1.69398469 |
143 | Spinal cord lesions (HP:0100561) | 1.69352990 |
144 | Syringomyelia (HP:0003396) | 1.69352990 |
145 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.69202648 |
146 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.69202648 |
147 | Abnormality of glycolipid metabolism (HP:0010969) | 1.69202648 |
148 | Neonatal death (HP:0003811) | 1.67929776 |
149 | Epiphyseal dysplasia (HP:0002656) | 1.66939294 |
150 | Breech presentation (HP:0001623) | 1.66663847 |
151 | Mitral valve prolapse (HP:0001634) | 1.66535104 |
152 | Broad metatarsal (HP:0001783) | 1.66190052 |
153 | Abnormality of nucleobase metabolism (HP:0010932) | 1.66170900 |
154 | Asymmetric septal hypertrophy (HP:0001670) | 1.65452412 |
155 | Abnormal hand bone ossification (HP:0010660) | 1.64433839 |
156 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.63975781 |
157 | Exostoses (HP:0100777) | 1.63491918 |
158 | Exocrine pancreatic insufficiency (HP:0001738) | 1.63398814 |
159 | Long palpebral fissure (HP:0000637) | 1.63107082 |
160 | Retinal atrophy (HP:0001105) | 1.62991003 |
161 | Congenital glaucoma (HP:0001087) | 1.61965021 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 5.14336008 |
2 | TRIB3 | 4.04799719 |
3 | PASK | 3.04258307 |
4 | SMG1 | 3.01241851 |
5 | PKN2 | 2.88180425 |
6 | INSRR | 2.83428427 |
7 | TAOK3 | 2.67996474 |
8 | FLT3 | 2.56269542 |
9 | ICK | 2.51536544 |
10 | BCKDK | 2.35974677 |
11 | SIK1 | 2.32301056 |
12 | PRPF4B | 2.21678249 |
13 | EPHA3 | 2.06231191 |
14 | SCYL2 | 1.90971365 |
15 | PDGFRA | 1.90834447 |
16 | CDK12 | 1.90358810 |
17 | PTK6 | 1.89839050 |
18 | LATS2 | 1.81249956 |
19 | TESK1 | 1.80803174 |
20 | LATS1 | 1.74487832 |
21 | FGFR4 | 1.70809587 |
22 | MAPK15 | 1.61895180 |
23 | FRK | 1.58910359 |
24 | MAP3K3 | 1.56144918 |
25 | EEF2K | 1.54269093 |
26 | RIPK1 | 1.53592389 |
27 | ARAF | 1.47334642 |
28 | LMTK2 | 1.41291167 |
29 | MAP3K10 | 1.40049861 |
30 | PTK2 | 1.38848152 |
31 | TTN | 1.37437399 |
32 | TAOK2 | 1.30014693 |
33 | JAK3 | 1.28599517 |
34 | TBK1 | 1.26547548 |
35 | PIK3CG | 1.26026364 |
36 | NEK9 | 1.23483728 |
37 | PRKD3 | 1.18952582 |
38 | HIPK2 | 1.17517854 |
39 | LRRK2 | 1.15791547 |
40 | RPS6KA4 | 1.15675997 |
41 | EPHA2 | 1.12383178 |
42 | DDR2 | 1.11116062 |
43 | MET | 1.10822674 |
44 | MYLK | 1.06185396 |
45 | ZAP70 | 1.04848582 |
46 | TYK2 | 1.04656340 |
47 | MAPKAPK3 | 1.03809084 |
48 | EPHB1 | 1.02791349 |
49 | MAP3K2 | 1.01314231 |
50 | DYRK1B | 1.00851370 |
51 | MAP2K3 | 0.94069134 |
52 | PAK4 | 0.92099579 |
53 | IRAK3 | 0.91276659 |
54 | TESK2 | 0.90066889 |
55 | NME2 | 0.89780111 |
56 | MAP3K1 | 0.89067483 |
57 | MOS | 0.88897986 |
58 | EIF2AK3 | 0.88762579 |
59 | KDR | 0.87408668 |
60 | EPHB2 | 0.85675634 |
61 | BRSK2 | 0.81092142 |
62 | JAK1 | 0.79764272 |
63 | MAP2K2 | 0.78883920 |
64 | STK10 | 0.78089677 |
65 | PRKD2 | 0.77112864 |
66 | MST1R | 0.72699674 |
67 | CLK1 | 0.72594326 |
68 | CDK7 | 0.72570571 |
69 | TGFBR1 | 0.71679765 |
70 | MTOR | 0.71540258 |
71 | FER | 0.70072312 |
72 | JAK2 | 0.68866746 |
73 | PAK2 | 0.68249853 |
74 | MAP3K8 | 0.65947558 |
75 | MAP3K11 | 0.65945974 |
76 | PDPK1 | 0.64419901 |
77 | ACVR1B | 0.64272900 |
78 | PIM2 | 0.62991637 |
79 | STK3 | 0.62110674 |
80 | CSK | 0.60372494 |
81 | RPS6KA2 | 0.59850821 |
82 | BRAF | 0.59479618 |
83 | TGFBR2 | 0.59404754 |
84 | PRKG2 | 0.57589252 |
85 | RET | 0.57094758 |
86 | PAK3 | 0.56361152 |
87 | MAP3K13 | 0.56275914 |
88 | PBK | 0.55593002 |
89 | FGFR3 | 0.55440233 |
90 | STK38 | 0.55429986 |
91 | BTK | 0.53884605 |
92 | ERBB4 | 0.53520128 |
93 | LIMK1 | 0.53303895 |
94 | CHUK | 0.53302290 |
95 | RPS6KB2 | 0.52469673 |
96 | ITK | 0.52241094 |
97 | TAOK1 | 0.51903062 |
98 | MAPK11 | 0.50896759 |
99 | CDK8 | 0.50513338 |
100 | MAP3K14 | 0.50205623 |
101 | PDGFRB | 0.49851220 |
102 | NTRK1 | 0.49592718 |
103 | MAP3K6 | 0.47672868 |
104 | NEK1 | 0.46109891 |
105 | BMX | 0.45915312 |
106 | IRAK1 | 0.45761008 |
107 | STK38L | 0.44719882 |
108 | MAP4K1 | 0.44676584 |
109 | CDK6 | 0.44338852 |
110 | MAP2K1 | 0.44271772 |
111 | WNK4 | 0.43757594 |
112 | CDK9 | 0.41159140 |
113 | CDK4 | 0.40276998 |
114 | TTK | 0.40194213 |
115 | EIF2AK1 | 0.38873317 |
116 | MAPKAPK2 | 0.38863493 |
117 | RAF1 | 0.38688421 |
118 | TRPM7 | 0.38443134 |
119 | PAK1 | 0.38129425 |
120 | ILK | 0.37058896 |
121 | ABL2 | 0.36748453 |
122 | ROCK2 | 0.36685186 |
123 | NLK | 0.36643867 |
124 | AKT2 | 0.36190515 |
125 | IRAK2 | 0.35106439 |
126 | MELK | 0.34466490 |
127 | KSR2 | 0.34194074 |
128 | DAPK3 | 0.33787616 |
129 | IGF1R | 0.31189523 |
130 | DYRK3 | 0.31155020 |
131 | CDC42BPA | 0.30897762 |
132 | CAMK1D | 0.30718346 |
133 | PRKCH | 0.29996991 |
134 | BUB1 | 0.29887639 |
135 | CAMKK2 | 0.28921145 |
136 | GSK3A | 0.27998355 |
137 | IRAK4 | 0.27130983 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.43219431 |
2 | Protein export_Homo sapiens_hsa03060 | 3.56863635 |
3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.24559123 |
4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.56099063 |
5 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.54601766 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.26098714 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02549646 |
8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.02274695 |
9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.98104234 |
10 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86110020 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.81226107 |
12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80147436 |
13 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.79535650 |
14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.72926478 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.66994583 |
16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.62732293 |
17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55721507 |
18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53778299 |
19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49372856 |
20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46550019 |
21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46337289 |
22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.45941198 |
23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.45782125 |
24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.44945371 |
25 | Lysosome_Homo sapiens_hsa04142 | 1.42399092 |
26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.34042525 |
27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24329782 |
28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.21482153 |
29 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.21190362 |
30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.19270147 |
31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17957906 |
32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16019333 |
33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.14544979 |
34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11845076 |
35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.10088071 |
36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09337997 |
37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08657595 |
38 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.06599781 |
39 | Insulin resistance_Homo sapiens_hsa04931 | 1.04680457 |
40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.02636865 |
41 | Peroxisome_Homo sapiens_hsa04146 | 1.01605947 |
42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01541039 |
43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00714684 |
44 | Legionellosis_Homo sapiens_hsa05134 | 1.00225206 |
45 | Shigellosis_Homo sapiens_hsa05131 | 0.95572725 |
46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95479140 |
47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94930596 |
48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94460681 |
49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90622499 |
50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88686990 |
51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87771374 |
52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86352172 |
53 | Bladder cancer_Homo sapiens_hsa05219 | 0.85791847 |
54 | Lysine degradation_Homo sapiens_hsa00310 | 0.84936003 |
55 | ABC transporters_Homo sapiens_hsa02010 | 0.84045019 |
56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84028746 |
57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83407654 |
58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82993804 |
59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82458114 |
60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81856246 |
61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81509572 |
62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80586495 |
63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79658842 |
64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77456705 |
65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.76366095 |
66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76360724 |
67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75949912 |
68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74067598 |
69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73950440 |
70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73518871 |
71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72861044 |
72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72693165 |
73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72690252 |
74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72307917 |
75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70898460 |
76 | Salmonella infection_Homo sapiens_hsa05132 | 0.70319868 |
77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70031978 |
78 | Prostate cancer_Homo sapiens_hsa05215 | 0.68513834 |
79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68512834 |
80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68391235 |
81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67383354 |
82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65092389 |
83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64773101 |
84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63792484 |
85 | Bile secretion_Homo sapiens_hsa04976 | 0.63272440 |
86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63186847 |
87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62980000 |
88 | Hepatitis C_Homo sapiens_hsa05160 | 0.62488761 |
89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61834814 |
90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60312158 |
91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59302089 |
92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59201349 |
93 | Prion diseases_Homo sapiens_hsa05020 | 0.59145189 |
94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59092555 |
95 | Glioma_Homo sapiens_hsa05214 | 0.58408225 |
96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58120650 |
97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56002950 |
98 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.55696890 |
99 | Focal adhesion_Homo sapiens_hsa04510 | 0.55401587 |
100 | Amoebiasis_Homo sapiens_hsa05146 | 0.55283967 |
101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54708049 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.54588627 |
103 | Hepatitis B_Homo sapiens_hsa05161 | 0.52995859 |
104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52993747 |
105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50131617 |
106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49540379 |
107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49506465 |
108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49036450 |
109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48288602 |
110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48108296 |
111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47743251 |
112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47121854 |
113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46844916 |
114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46812737 |
115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46100807 |
116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45578323 |
117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45320787 |
118 | Pertussis_Homo sapiens_hsa05133 | 0.45136470 |
119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44703439 |
120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44554403 |
121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43764196 |
122 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.43071434 |
123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42158077 |
124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41689182 |
125 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41529880 |
126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40613495 |
127 | Adherens junction_Homo sapiens_hsa04520 | 0.40277355 |
128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40174151 |
129 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40157327 |
130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37488131 |
131 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37334220 |
132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36586713 |
133 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36306522 |
134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35894728 |
135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34696582 |
136 | Apoptosis_Homo sapiens_hsa04210 | 0.33736264 |
137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33462542 |
138 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33224308 |
139 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32330888 |